RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Algernon Pharmaceuticals - Stock

Algernon Pharmaceuticals Liabilities 2024

Algernon Pharmaceuticals Liabilities

2.72 M CAD

Ticker

AGN.CN

ISIN

CA01559R4008

WKN

A3DAFG

In 2024, Algernon Pharmaceuticals's total liabilities amounted to 2.72 M CAD, a 8.09% difference from the 2.52 M CAD total liabilities in the previous year.

Algernon Pharmaceuticals Aktienanalyse

What does Algernon Pharmaceuticals do?

Algernon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Algernon Pharmaceuticals's Liabilities

Algernon Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Algernon Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Algernon Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Algernon Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Algernon Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Algernon Pharmaceuticals Stock

What is the level of liabilities of Algernon Pharmaceuticals this year?

Algernon Pharmaceuticals has a debt balance of 2.72 M CAD this year.

What were the liabilities of Algernon Pharmaceuticals compared to the previous year?

The liabilities of Algernon Pharmaceuticals have increased by 8.09% increased compared to the previous year.

What are the consequences of high debt for investors of Algernon Pharmaceuticals?

High liabilities can pose a risk for investors of Algernon Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Algernon Pharmaceuticals?

Low liabilities mean that Algernon Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Algernon Pharmaceuticals affect the company?

An increase in liabilities of Algernon Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Algernon Pharmaceuticals affect the company?

A decrease in the liabilities of Algernon Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Algernon Pharmaceuticals?

Some factors that can influence the liabilities of Algernon Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Algernon Pharmaceuticals so important for investors?

The liabilities of Algernon Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Algernon Pharmaceuticals take to modify the liabilities?

To change its liabilities, Algernon Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Algernon Pharmaceuticals pay?

Over the past 12 months, Algernon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Algernon Pharmaceuticals is expected to pay a dividend of 0 CAD.

What is the dividend yield of Algernon Pharmaceuticals?

The current dividend yield of Algernon Pharmaceuticals is .

When does Algernon Pharmaceuticals pay dividends?

Algernon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Algernon Pharmaceuticals?

Algernon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Algernon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Algernon Pharmaceuticals located?

Algernon Pharmaceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Algernon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Algernon Pharmaceuticals from 6/24/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.

When did Algernon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Algernon Pharmaceuticals in the year 2023?

In the year 2023, Algernon Pharmaceuticals distributed 0 CAD as dividends.

In which currency does Algernon Pharmaceuticals pay out the dividend?

The dividends of Algernon Pharmaceuticals are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Algernon Pharmaceuticals

Our stock analysis for Algernon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Algernon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.